SWTX NASDAQ
SpringWorks Therapeutics, Inc.
1W: +0.0%
1M: +0.7%
3M: +12.2%
1Y: +24.7%
3Y: +76.1%
5Y: +5.5%
$46.99
Last traded 2025-07-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$192M
+3417.3% ▲
Gross Profit
$179M
+3463.0% ▲
Operating Income
-$278M
+18.9% ▲
Net Income
-$258M
+20.6% ▲
EPS (Diluted)
$-3.48
+32.4% ▲
EBITDA
-$275M
+18.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $35M | $0 | $6M | $5M | $192M |
| YoY Growth | +0.0% | -100.0% | +0.0% | -11.4% | +3417.3% |
| Cost of Revenue | $349K | $490K | $2M | $422K | $13M |
| Gross Profit | $35M | -$490K | $4M | $5M | $179M |
| Gross Margin | 99.0% | — | 69.2% | 92.3% | 93.4% |
| R&D Expenses | $52M | $102M | $146M | $150M | $201M |
| SG&A Expenses | $29M | $72M | $135M | $198M | $257M |
| Operating Expenses | $81M | $173M | $279M | $348M | $457M |
| Operating Income | -$46M | -$173M | -$281M | -$343M | -$278M |
| Operating Margin | -132.4% | — | -4566.0% | -6297.3% | -145.2% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$46M | -$174M | -$277M | -$325M | -$258M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$46M | -$173M | -$277M | -$325M | -$258M |
| Net Margin | -130.2% | — | -4513.0% | -5968.5% | -134.7% |
| EPS (Diluted) | $-1.05 | $-3.59 | $-5.21 | $-5.15 | $-3.48 |
| EBITDA | -$46M | -$173M | -$276M | -$341M | -$275M |
| Shares Outstanding | 43M | 48M | 53M | 63M | 74M |